CC BY-NC-ND 4.0 · Journal of Gastrointestinal Infections 2023; 13(01): 034-037
DOI: 10.1055/s-0043-1768144
Brief Report

Infections in Patients with Severe Alcoholic Hepatitis: A Retrospective Study

1   Arihant Hospital and Research Centre, Indore, India
› Author Affiliations
Zoom Image

Abstract

Introduction Severe alcoholic hepatitis (SAH) is the severest type of alcohol-related liver disease and is fraught with risk of infectious complications. The present study was done to determine the frequency and types of infections noted in patients with SAH at baseline evaluation.

Methods This is a retrospective analysis of patients with alcoholic hepatitis treated at our center between 2019 and 2022. Details of age, gender, baseline laboratory parameters, and clinical presentation were noted. All patients were screened for infections to ascertain the suitability for steroid use as per protocol. Diagnosis of infections was done as per the North American Consortium for the Study of End Stage Liver Disease (NACSELD) criteria. In culture-positive infections, the details of the microorganisms that were isolated and antibiotic susceptibility patterns were recorded.

Results A total of 66 patients with SAH formed the study cohort (median age: 42 years; 100% males). The majority of them had underlying cirrhosis (33 [50%]) and 26 had acute-on-chronic liver failure. Twenty-eight (42.4%) cases had bacterial infections. Spontaneous bacterial peritonitis (10 [35.7%]) was the commonest infection, followed by urinary tract infection (8 [28.5%]), lower respiratory infections (7 [25%]), and skin infections (3 [10.7%]). Culture positivity was noted in 12 cases (42.9%). The commonest organism cultured was Escherichia coli (6 cases), followed by Klebsiella pneumoniae (cases). Multidrug-resistant (MDR) infections were noted in nine (13.6%) cases. Two patients had tuberculosis.

Conclusion In all, 42.4% of patients with SAH had bacterial infections at baseline evaluation. Spontaneous bacterial peritonitis was the commonest infection. MDR bacterial infections were noted in nine cases (13.6%).

Consent and Ethical Clearance

Ethical clearance was obtained via letter no. AHRC/IEC/2022/6. The need for informed consent was waived due to the retrospective nature of the study.


Authors' Contribution

All the authors contributed equally to the article.


Data Availability

Data can be shared by the author on a reasonable request.




Publication History

Received: 11 June 2023

Accepted: 20 February 2023

Article published online:
22 September 2023

© 2023. Gastroinstestinal Infection Society of India. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India